Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
May 28, 2013
Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program
Catherine Kim, Xavier Pi-Sunyer, Elizabeth Barrett-Connor, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1993
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
P R Casson, R N Andersen, H G Herrod, et al.
Fertility and Sterility
|
May 1, 1995
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women
P R Casson, L C Faquin, F B Stentz, et al.
Diabetes
|
December 1, 1984
In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance
B R Blazar, C B Whitley, A E Kitabchi, et al.
Diabetes Care
|
February 14, 2013
Effects of high-protein versus high-carbohydrate diets on markers of β-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: a randomized controlled trial
Abbas E Kitabchi, Kristin A McDaniel, Jim Y Wan, et al.
Metabolism: Clinical and Experimental
|
March 24, 2009
Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
Laleh Razavi Nematollahi, Abbas E Kitabchi, Abbas Eghbal Kitabchi, et al.
Metabolism: Clinical and Experimental
|
August 1, 1995
Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease
T A Hughes, M B Elam, W B Applegate, et al.
BMC Endocrine Disorders
|
July 31, 2009
Actos Now for the prevention of diabetes (ACT NOW) study
Ralph A Defronzo, Maryann Banerji, George A Bray, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
Diabetes Care
|
April 8, 2014
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW
Devjit Tripathy, Stephen C Clement, Dawn C Schwenke, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
The Journal of Clinical Endocrinology and Metabolism
|
May 28, 2013
Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program
Catherine Kim, Xavier Pi-Sunyer, Elizabeth Barrett-Connor, et al.
American Journal of Obstetrics and Gynecology
|
December 1, 1993
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
P R Casson, R N Andersen, H G Herrod, et al.
Fertility and Sterility
|
May 1, 1995
Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women
P R Casson, L C Faquin, F B Stentz, et al.
Diabetes
|
December 1, 1984
In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance
B R Blazar, C B Whitley, A E Kitabchi, et al.
Diabetes Care
|
February 14, 2013
Effects of high-protein versus high-carbohydrate diets on markers of β-cell function, oxidative stress, lipid peroxidation, proinflammatory cytokines, and adipokines in obese, premenopausal women without diabetes: a randomized controlled trial
Abbas E Kitabchi, Kristin A McDaniel, Jim Y Wan, et al.
Metabolism: Clinical and Experimental
|
March 24, 2009
Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects
Laleh Razavi Nematollahi, Abbas E Kitabchi, Abbas Eghbal Kitabchi, et al.
Metabolism: Clinical and Experimental
|
August 1, 1995
Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease
T A Hughes, M B Elam, W B Applegate, et al.
BMC Endocrine Disorders
|
July 31, 2009
Actos Now for the prevention of diabetes (ACT NOW) study
Ralph A Defronzo, Maryann Banerji, George A Bray, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 17, 2016
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
Devjit Tripathy, Dawn C Schwenke, MaryAnn Banerji, et al.
Diabetes Care
|
April 8, 2014
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW
Devjit Tripathy, Stephen C Clement, Dawn C Schwenke, et al.
Page
of 5